• George has advised numerous insurance sector clients on 'Brexit' (including in relation to proposed restructurings, set ups and authorisations, redomiciliations and portfolio transfers, and associated licensing issues). He has also advised groups on post-Brexit licensing issues, including run-off and temporary permission regimes.
  • He has advised a number of clients on insurance regulation issues concerned with setting up in the UK and Europe, and on operating compliantly with PRA and FCA regulation.
  • He advised Aetna, one of the world's biggest health insurance groups, on regulatory issues related to its merger with the largest pharmacy corporation in the US (CVS), (reportedly the largest corporate transaction of 2017, anywhere in the world). This involved global regulatory advice and advice on change in control processes for the Aetna regulated insurer and insurance intermediary entities in the UK, Ireland, Bermuda, Canada, UAE, Hong Kong and Singapore, Indonesia and PRC.
  • He advised the liquidators of CBL Insurance on the commutation of their reinsurance contracts with a Gibraltar ceding company. This was a highly complex transaction for New Zealand based clients, requiring the coordination of advice from Gibraltar, Ireland and the US.
  • He advised a major insurer on the development of one of the first COVID-19 specific personal accident insurance products for the UK and European market, and has advised numerous insurers on regulatory issues arising from the coronavirus pandemic, including in relation to the FCA's guidance on business interruption claims.